Acetazolamide

6 trials 3 recruiting SOphthalmology & ENT

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

0 Completed trials

6 Sponsors

5 Countries

Phase III

Phase IV

Phase I (Other)

Phase I (FiH)

Phase III: 3 Phase IV: 1 Phase I (Other): 1 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Clear cell renal cell carcinoma 1 Retinitis pigmentosa 1 Ductal adenocarcinoma of pancreas 1 Colorectal cancer 1

Sponsors using this IMP

Beacon Therapeutics (USA) Inc. 1 Centre Antoine Lacassagne 1 Centro Cardiologico Monzino S.p.A. 1 ITM Oncologics GmbH 1 Region Hovedstaden 1 Ziekenhuis Oost Limburg 1

All trials

6 total

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pig… Not authorised

2024-511181-36-00 Phase III 1 country Beacon Therapeutics (USA) Inc.
Acetazolamide in combination with SGLT2i in patients with volume overload and acute heart failure Pending

2024-513799-16-00 Phase IV 1 country Ziekenhuis Oost Limburg
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of … Recruiting

2023-504254-35-00 Phase I (FiH) 2 countries ITM Oncologics GmbH
OPTIMAL DIURETIC THERAPIES FOR ACUTE HEART FAILURE WITH VOLUME OVERLOAD Recruiting

2024-510633-17-00 Phase III 1 country Region Hovedstaden
Effects of combined diuretic therapy on exercise capacity, alveolar-capillary diffusion and maintenance of euvolemia in chronic congestive h… Recruiting

2024-519565-21-01 Phase III 1 country Centro Cardiologico Monzino S.p.A.
Phase I trial of CArbonic Anhydrase Inhibition in combination with radiochemotherapy or radioimmunotherapy in small cell lung carcinoma (ICA… Halted

2022-503093-36-00 Phase I (Other) 1 country Centre Antoine Lacassagne

Showing 1–6 of 6 trials

← All drugs A–Z